Table 3.

Primary end-points: complications and cumulative 30-day clinical outcomes

Variable	Entire patients			Matched patients
	Radial (n = 220)	Femoral (n = 469)	p value	Radial (n = 171)	Femoral (n = 171)	p value
Procedural complications	35 (15.9)	65 (13.8)	0.476	25 (14.6)	26 (15.2)	0.879
Dissection	2 (0.9)	14 (2.9)	0.092	1 (0.5)	5 (2.9)	0.215
Perforation	2 (0.9)	2 (0.4)	0.596	1 (0.5)	1 (0.5)	NS
Acute thrombosis	2 (0.9)	3 (0.6)	0.657	2 (1.1)	2 (1.1)	NS
Distal embolization	2 (0.9)	2 (0.4)	0.596	1 (0.5)	2 (1.1)	NS
No reflow	16 (7.2)	27 (5.7)	0.443	11 (6.4)	10 (5.8)	0.822
Side branch occlusion	11 (5.0)	15 (3.1)	0.247	9 (5.2)	5 (2.9)	0.275
Access site complications
Dissection	0	1 (0.2)	NS	0	1 (0.5)	NS
Hematoma	0	17 (3.6)	0.004	0	8 (4.6)	0.007
Major (≥ 4 cm)	0	3 (0.6)	0.555	0	2 (1.1)	0.499
Minor (< 4 cm)	0	14 (2.9)	0.007	0	6 (3.5)	0.030
In-hospital complications
Cardiogenic shock	6 (2.7)	12 (2.5)	0.897	4 (2.3)	4 (2.3)	NS
Acute renal failure	2 (0.9)	2 (0.4)	0.596	1 (0.5)	0 (0.0)	NS
Acute heart failure	2 (0.9)	5 (1.0)	NS	1 (0.5)	2 (1.1)	NS
Stroke	1 (0.4)	3 (0.6)	NS	1 (0.5)	1 (0.5)	NS
Gastrointestinal bleeding	1 (0.4)	1 (0.2)	0.537	1 (0.5)	0	NS
Transfusion	6 (2.7)	19 (4.0)	0.386	3 (1.7)	7 (4.0)	0.199
Transfusion (Pint)	3.3 ± 2.1	4.4 ± 7.5	0.623	3.3 ± 1.1	3.0 ± 3.1	0.197
Contrast reaction	7 (3.1)	6 (1.2)	0.129	3 (1.7)	1 (0.5)	0.623
Contrast induced nephropathy	6 (2.7)	4 (0.8)	0.082	2 (1.1)	1 (0.5)	NS
30-Day outcomes after procedure
Total death	6 (2.7)	10 (2.1)	0.629	4 (2.3)	2 (1.1)	0.685
Cardiac death	4 (1.8)	9 (1.9)	NS	2 (1.1)	2 (1.1)	NS
Recurrent MI	0	3 (0.6)	0.555	0	1 (0.5)	NS
NSTEMI	0	3 (0.6)	0.555	0	1 (0.5)	NS
Revascularizations	0	6 (1.2)	0.184	0	2 (1.1)	0.499
Target lesion	0	6 (1.2)	0.184	0	2 (1.1)	0.499
Target vessel	0	6 (1.2)	0.184	0	2 (1.1)	0.499
Stent thrombosis	0	5 (1.0)	0.183	-	-	-

Values are presented as number (%) or mean ± SD.

NS, not significant (> 0.999); MI, myocardial infarction; NSTEMI, non-ST segment elevation MI.